Mr. Speaker, while Quebec strongly supports its biopharmaceutical industry, this Conservative government refuses to act on the issue of innovative pharmaceutical companies' right to appeal. This jeopardizes investments in research and development.
When will Canada create a fair right to appeal in terms of competition?